Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCity Lon Inv Regulatory News (CLIG)

Share Price Information for City Lon Inv (CLIG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 360.00
Bid: 351.00
Ask: 366.00
Change: 2.00 (0.56%)
Spread: 15.00 (4.274%)
Open: 358.00
High: 360.00
Low: 358.00
Prev. Close: 358.00
CLIG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Funds Under Management - Trading Update

17 Jan 2017 07:00

RNS Number : 2882U
City of London Investment Group PLC
17 January 2017
 

RNS Number:

City of London Investment Group PLC

17 January 2017



CITY OF LONDON INVESTMENT GROUP PLC

("City of London", the "Group" or the "Company")

 

FUNDS UNDER MANAGEMENT AS AT 31 DECEMBER 2016,

TRADING UPDATE

 

City of London (LSE: CLIG) announces that total funds under management (FuM) at the Group's half year end on 31 December 2016 were US$4.1 billion (£3.3 billion). This compares with US$4.0 billion (£3.0 billion) at the Company's year-end on 30 June 2016.

 

This rise in FuM of 2.5% compares with a gain of 4.5% in the MSCI Emerging Markets TR Index (NDUEEGF) over the six month period to 31 December 2016. Investment performance in the Emerging closed-end fund (CEF) strategy over the short term has been challenging. Our country allocation in 2016 was weak and this was compounded by poor net asset value (NAV) performances of the underlying CEFs. Discounts remain wide across the sector, with the current size-weighted average discount (SWAD) at c. 13%-14%, indicating significant value in the strategy.

 

With regards to business development, the Group continues to maintain an active pipeline across all of its major CEF offerings and has seen an increased interest in the diversification CEF strategies over the past 12 months. In total, the active pipeline is in excess of US$400 million, which includes opportunities that are spread across Emerging and Developed Markets, Global Tactical Asset Allocation, Tactical Income, and Frontier CEF strategies.

 

Operations

As of the end of December the monthly "run-rate" for operating profit, before profit-share of c.30%, is approximately £1.4 million per month based upon current FuM. The Group estimates the unaudited profit before taxation for the six months ended 31 December 2016 to be approximately £5.8 million, which compares with £3.6 million for the equivalent period to 31 December 2015.

 

The Company is currently in a close period which will end with the publication of results for the six months ended 31 December 2016 on 20 February 2017.

 

Template

Please see the attached graph which is based on the following assumptions and includes the estimated quarterly cost of a maintained dividend:

 

http://www.rns-pdf.londonstockexchange.com/rns/2882U_-2017-1-16.pdf

 

Key assumptions:

 

(June 2016 comparatives in Italics)

· Starting point Current FuM (end December 2016)

· Net increase for the remainder of this financial year (straight-lined to June 2017):

- emerging market CEF strategy US$125m (US$250m over full year)

- non-emerging market CEF strategies US$125m (US$250m over the full year)

· Net increase in 2017/2018 (straight-lined to June 2018):

- emerging market CEF strategy US$125m

- non-emerging market CEF strategies US$125m

· Operating margin adjusted monthly for change in product mix and commission run-off

· Market growth: 0%

· Overheads for 2016/17: +10% compared to 2015/16 (+5%)

· Overheads for 2017/18: +11% compared to 2015/16

· EIP cost for 2016/17: 0.5% of operating profit

· EIP cost for 2017/18: 2% of operating profit

· Corporation tax based on an estimated average rate of 26% (26%)

· Exchange rate assumed to be £1/$1.23 for entire period (£1/US$1.35)

· Number of CLIG Shares in issue (26.9m) less those held by the ESOP Trust (1.7m) as at 31 December 2016 (26.9 m CLIG shares in issue less 1.9m ESOP Trust holding)

 

For further information, please visit http://www.citlon.co.uk/ or contact:

 

Barry Olliff, CEO

City of London Investment Group PLC

Tel: 001 215 313 3774

 

Martin Green

Zeus Capital Limited

Financial Adviser & Broker

Tel: +44 (0)20 3829 5000

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGGUUCGUPMGQQ
Date   Source Headline
20th Feb 20094:09 pmRNSDividend reinvestment plan
11th Feb 20094:55 pmRNSHolding(s) in Company
9th Feb 200911:03 amRNSDirector/PDMR Shareholding
4th Feb 20093:16 pmRNSDirector/PDMR Shareholding
4th Feb 200912:04 pmRNSHolding(s) in Company
30th Jan 20099:32 amRNSTotal Voting Rights
28th Jan 20094:02 pmRNSDirector/PDMR Shareholding & TVR
28th Jan 20097:00 amRNSHalf Yearly Report
21st Jan 200912:16 pmRNSHolding(s) in Company
13th Jan 20099:00 amRNSBlock Admission & TVR
8th Dec 20087:34 amRNSFunds under Management - Replacement
8th Dec 20087:00 amRNSFunds Under Management
27th Nov 20084:31 pmRNSDirector/PDMR Shareholding
7th Nov 20089:09 amRNSDirector/PDMR Shareholding
3rd Nov 20087:00 amRNSChange of Registered Office
28th Oct 20087:00 amRNSResult of AGM
27th Oct 20087:00 amRNSAGM Trading Update
8th Oct 200810:01 amRNSChange of Adviser Name
30th Sep 200812:18 pmRNSDirector/PDMR Shareholding
30th Sep 200810:04 amRNSDirector/PDMR Shareholding
22nd Sep 20081:04 pmRNSNotifiable Interest
15th Sep 20087:00 amRNSFinal Results
14th Jul 20086:03 pmRNSDirector/PDMR Shareholding
10th Jun 20087:00 amRNSDirector/PDMR Shareholding
9th Jun 20087:00 amRNSTrading Update
19th May 20082:34 pmRNSDirectorate Change
28th Apr 20083:50 pmRNSNotifiable Interest
23rd Apr 20087:00 amRNSNotifiable Interest
18th Apr 20085:00 pmRNSNotifiable Interest
18th Apr 20083:36 pmRNSDirector/PDMR Shareholding
31st Mar 20089:56 amRNSTotal Voting Rights
27th Mar 20087:01 amRNSDirector/PDMR Shareholding
26th Mar 20082:24 pmRNSAppointment of Joint Broker
17th Mar 200810:51 amRNSNotifiable Interest
10th Mar 20087:00 amRNSFunds Under Management
29th Feb 20085:01 pmRNSNotifiable Interest
29th Feb 20085:00 pmRNSNotifiable Interest
29th Feb 20087:01 amRNSBuyback & Directors' Dealing
7th Feb 20089:57 amRNSDirector/PDMR Shareholding
6th Feb 20087:01 amRNSDirector/PDMR Shareholding
29th Jan 20087:00 amRNSInterim Results
18th Jan 200811:47 amRNSNotice of Results Correction
18th Jan 20089:07 amRNSNotice of Results
10th Dec 20077:00 amRNSFunds Under Management
30th Nov 20077:01 amRNSDirector/PDMR Shareholding
29th Oct 200712:44 pmRNSResult of AGM
29th Oct 20077:00 amRNSTrading Update
24th Sep 20073:38 pmRNSDirector/PDMR Shareholding
19th Sep 20074:32 pmRNSDirector/PDMR Shareholding
17th Sep 20077:01 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.